Answers are grounded in this paper and cite their sources.
A series of new Schiff bases bearing 1,2,3-triazole 12a-o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug acarbose. The kinetic study on the most potent compound 12n showed that this compound acted as a competitive α-glucosidase inhibitor. The docking study revealed that the synthesized compounds interacted with the important residues in the active site of α-glucosidase.
No takes yet. Share an insight, caveat, or question.
Nasli‐Esfahani et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: